A Screen of Natural Product Extracts Identifies Moenomycin as a Potent Antigonococcal Agent
- 7 April 2021
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 7 (6) , 1569-1577
Abstract
Increasing multidrug resistance in Neisseria gonorrheae is a growing public health crisis. Resistance to the last line therapies, cephalosporins and azithromycin, are of particular concern, fueling the need to discover new treatments. Here, we identified the phosphoglycolipid moenomycin from a screen of microbial natural products against drug-resistant N. gonorrheae as a potent antigonococcal agent. Moenomycin demonstrates excellent activity (MIC = 0.004–0.03 μg/mL) against a variety of multidrug-resistant N. gonorrheae. Importantly, moenomycin, thought to be a Gram-positive specific antibiotic, penetrates the Gram-negative gonococcal outer membrane. Moenomycin causes intracellular accumulation of peptidoglycan precursors, cell blebbing, and rupture of the cell envelope, all consistent with cell wall biosynthesis inhibition. Serial bacterial exposure to moenomycin for 14 days revealed slow development of resistance (MICDay14 = 0.03–0.06 μg/mL), unlike the clinically used drug azithromycin. Our results offer the potential utility of moenomycin as a lead for antigonococcal therapeutic candidates and warrant further investigation.Keywords
Funding Information
- Ontario Research Fund
- Canadian Institutes of Health Research
This publication has 27 references indexed in Scilit:
- Opportunities for natural products in 21st century antibiotic discoveryNatural Product Reports, 2017
- Predictive compound accumulation rules yield a broad-spectrum antibioticNature, 2017
- The novel 2016 WHONeisseria gonorrhoeaereference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterizationJournal of Antimicrobial Chemotherapy, 2016
- Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of actionCellular and Molecular Life Sciences, 2016
- A gene cluster for the biosynthesis of moenomycin family antibiotics in the genome of teicoplanin producer Actinoplanes teichomyceticusApplied Microbiology and Biotechnology, 2016
- Diffusion of Antibiotics through the PilQ Secretin in Neisseria gonorrhoeae Occurs through the Immature, Sodium Dodecyl Sulfate-Labile FormJournal of Bacteriology, 2015
- Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and FutureClinical Microbiology Reviews, 2014
- Immunization against a Saccharide Epitope Accelerates Clearance of Experimental Gonococcal InfectionPLOS Pathogens, 2013
- Moenomycin family antibiotics: chemical synthesis, biosynthesis, and biological activityNatural Product Reports, 2010
- Cell envelope of Neisseria gonorrhoeae. A comparative study with Escherichia coli.Sexually Transmitted Infections, 1976